Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,398
Closed -$48K 2882
2021
Q1
$48K Buy
+1,398
New +$59.7K ﹤0.01% 1653
2020
Q2
Sell
-1,780
Closed -$48K 2566
2020
Q1
$48K Sell
1,780
-100
-5% -$3.15K ﹤0.01% 1123
2019
Q4
$62K Hold
1,880
﹤0.01% 1147
2019
Q3
$79K Hold
1,880
﹤0.01% 981
2019
Q2
$93K Sell
1,880
-12
-0.6% -$518 0.01% 935
2019
Q1
$78K Sell
1,892
-400
-17% -$14K 0.01% 951
2018
Q4
$69K Sell
2,292
-1,500
-40% -$55.3K 0.01% 962
2018
Q3
$184K Buy
3,792
+12
+0.3% +$650 0.01% 670
2018
Q2
$206K Hold
3,780
0.02% 560
2018
Q1
$173K Buy
3,780
+200
+6% +$7.86K 0.02% 576
2017
Q4
$112K Sell
3,580
-309
-8% -$9.98K 0.01% 706
2017
Q3
$127K Buy
+3,889
New +$123K 0.01% 637

Other funds holding BZUN

Geneos Wealth Management's BZUN Position: Q2 2021 in Review

Geneos Wealth Management sold out of Baozun (BZUN) in Q2 2021, closing a stake of 1,398 shares — an estimated $48K sold.

Geneos Wealth Management first reported a position in BZUN in Q3 2017 and held it in 12 quarters. The position peaked at $206K in Q2 2018. 185 funds tracked by Wall St. Rank hold BZUN as of Q2 2021.

  • Geneos Wealth Management reported no remaining Baozun position as of Q2 2021 after selling out during the quarter.
  • Geneos Wealth Management sold 1,398 Baozun shares in Q2 2021, an estimated $48K.
  • Geneos Wealth Management first reported a position in Baozun in Q3 2017 and held it in 12 quarters.
  • Geneos Wealth Management's Baozun position peaked at $206K in Q2 2018.
  • 185 funds tracked by Wall St. Rank held Baozun as of Q2 2021.

Based on Geneos Wealth Management's 13F filing for Q2 2021, filed 8 Jul 2021.